← back to search

Yu Feng

Shanxi Medical University · CN
Area of research
Immunology · Oncology
Research interest
Research focused on Immune checkpoint and Apoptosis, with related work in Cancer research, Blockade, Fatty liver. Notable publications include 'Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma', 'A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma', and 'Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver'.
h-index
citations
557
works
6
NIH funding
primary concept
email

Recent publications

StereoMM: a graph fusion model for integrating spatial transcriptomic data and pathological images
Briefings in Bioinformatics 2025cited by 6position: middledoi
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
Nature Communications 2024cited by 63position: firstdoi
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver
Cellular and Molecular Immunology 2022cited by 100position: middledoi
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
Science Translational Medicine 2021cited by 157position: middledoi
Resveratrol Derivative, Trans‐3, 5, 4 <sup>′</sup>‐Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS‐Induced Caspases Activation
Oxidative Medicine and Cellular Longevity 2021cited by 18position: firstdoi
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Gut 2019cited by 176position: middledoi
A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae
Chinese Medicine 2019cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jingying Zhou · Wenzhou Medical University3 papers (2019–2024)Weiqin Yang · Chinese University of Hong Kong2 papers (2019–2021)Anthony W.H. Chan · Beckman Research Institute2 papers (2019–2021)Hanyong Sun · Second Military Medical University2 papers (2019–2021) · 2 papers (2019–2021)John Wong · Second Military Medical University2 papers (2019–2021) · 2 papers (2019–2021)Ming Hong · Guangzhou University of Chinese Medicine2 papers (2019–2021)Stephen L. Chan · California Pacific Medical Center2 papers (2019–2021)Joseph J.�Y. Sung · Government Communications Headquarters2 papers (2019–2021)Ka‐Fai To · Chinese University of Hong Kong2 papers (2019–2021) · 2 papers (2019–2021)Ao Chen · BGI Group (China)2 papers (2024–2025)Zhiwei Chen · Beijing Information Science & Technology University2 papers (2019–2021)Feng Wu · Nanchang University2 papers (2019–2021)Siying Li · Beihua University1 papers (2019–2019)Wenyan Jiang · Nanchang University1 papers (2025–2025)Jian Cao · Chinese University of Hong Kong1 papers (2021–2021)Mohammed M. Almutairi · University of Idaho1 papers (2019–2019)Liangliang Xu · Zhejiang Sci-Tech University1 papers (2021–2021)